Pharmabiz10h
US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria
US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria: Paris Monday, November 18, 2024, 11:00 Hrs [IST] The US Food and Drug Admin ...
FDA Cellular, Tissue & Gene Therapies Advisory Committee holds virtual meeting
The Committee discusses and makes recommendations for AstraZeneca (AZN) supplemental Biologics License Application (sBLA) 125586/546 for ...
The Pharma Letter16h
FDA accepts Dupixent sBLA resubmission for CSU
The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental Biologics License ...
This celebrity-approved SLBA anti-aging eye treatment is 40% off ahead of Black Friday — 'it really works,' say shoppers
One popular item that shoppers rave about is the celeb-approved Eye Lift Wand from SBLA Beauty. Marketed as "the first-ever ...